Gene therapy modalities in lung transplantation

Fakher Rahim1, Ammar Ebrahimi2

  • 1Health Research Institute, Hearing Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Transplant Immunology
|August 28, 2014
PubMed

Insights

Genetic modification offers a promising strategy to overcome challenges in lung transplantation, such as immune rejection and donor shortages. This review examines gene therapy approaches to improve lung allograft survival in experimental models.

Area of Science:

  • Immunology
  • Regenerative Medicine
  • Transplantation Science

Background:

  • Lung transplantation is a critical treatment for end-stage organ failure.
  • Key challenges include systemic immunosuppression, chronic transplant dysfunction, and donor lung scarcity.
  • Genetic modification presents a potential solution to enhance transplant outcomes.

Purpose of the Study:

  • To review candidate genes and vector systems for genetic modification in lung transplantation.
  • To explore strategies for overcoming immune and non-immune barriers to lung allograft survival.
  • To summarize pre-clinical research on gene therapy for lung allografts.

Main Methods:

  • Literature review of pre-clinical studies on genetic modification for lung transplantation.
  • Analysis of various therapeutic concepts and vector systems.
  • Examination of experimental models investigating gene therapy approaches.

Main Results:

  • Multiple gene therapy strategies and vector systems have been investigated.
  • Genetic modification aims to protect allogeneic transplants from rejection and complications.
  • Research focuses on prolonging lung allograft survival through genetic manipulation.

Conclusions:

  • Genetic modification holds significant potential for improving lung transplant success.
  • Overcoming immune and non-immune barriers is crucial for enhancing allograft survival.
  • Further pre-clinical research is essential to translate these findings into clinical practice.

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
22.1K
Gene Therapy00:59

Gene Therapy

4.4K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.4K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
611